The bizarre phenomenon of the pharmaceutical industry with its 93 price earning ratio without any bubble controversy

Published: 2015-07-03 13:39:56

Updated: 2015-07-03 13:39:56

The average price earning ratio(PER) of the pharmaceutical industry is observed to be 93.4. PER, a ratio of a company’s current share price compared to its per-share earnings, indicates a number of times for a share price over per-share earnings.

Considering the average PER of listed pharmaceutical companies is close to 10, the one of the pharmaceutical industry is ‘way too high.’

At this poi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.